The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
The varying faces of IL-6: From cardiac protection to cardiac failure
Open accessAbstract
IL6 is a pleiotropic cytokine that is made in response to perturbations in homeostasis. IL6 becomes elevated in the acute response to host injury and can activate immune cells, direct immune cell trafficking, signal protective responses in local tissue, initial the acute phase response or initiate wound healing. In the short term this proinflammatory response is protective and limits host damage. It is when this acute response remains chronically activated that IL6 becomes pathogenic to the host. Chronically elevated IL6 levels lead to chronic inflammation and fibrotic disorders. The heart is a tissue where this temporal regulation of IL6 is very apparent. Studies from myocardial infarction show how short-term IL6 signaling can protect and preserve the heart tissue in response to acute damage, where long term IL6 signaling or an over-production of IL6R protein plays a causal role in cardiovascular disease. Thus, IL6 can be both protective and pathogenic, depending on the kinetics of the host response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“In addition, IL6 is required for Th17-lineage differentiation through STAT3 dependent mechanisms [55,56].”
BackgroundTransforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“In addition, IL6 is required for Th17-lineage differentiation through STAT3 dependent mechanisms [55,56].”
BackgroundInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928
The interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J., & Karolina Palucka, A. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906
Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S. D., Thut, C. J., McGourty, J., Brasher, K. K., King, J. A., Gillis, S., Mosley, B., et al. (1992) · Science · doi:10.1126/science.1542794 · Cited by 889
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Yokota, S., Imagawa, T., Mori, M., Miyamae, T., Aihara, Y., Takei, S., Iwata, N., Umebayashi, H., Murata, T., Miyoshi, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60454-7 · Cited by 789
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27
Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., & Kastelein, R. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2225 · Cited by 695
Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J., Yasukawa, K., Kishimoto, T., Anderson, D. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90634-o · Cited by 684
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Hirota, H., Chen, J., Betz, U. A. K., Rajewsky, K., Gu, Y., Ross, J., Müller, W., & Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80729-1 · Cited by 656
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Lin, Z.-Q., Kondo, T., Ishida, Y., Takayasu, T., & Mukaida, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0802397 · Cited by 585
Tsutamoto, T., Hisanaga, T., Wada, A., Maeda, K., Ohnishi, M., Fukai, D., Mabuchi, N., Sawaki, M., & Kinoshita, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00494-4 · Cited by 561
Lindmark, E., Diderholm, E., Wallentin, L., & Siegbahn, A. (2001) · JAMA · doi:10.1001/jama.286.17.2107 · Cited by 556
The paradigm of IL-6: from basic science to medicine
Naka, T., Nishimoto, N., & Kishimoto, T. (2002) · Arthritis Research · doi:10.1186/ar565 · Cited by 547
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Transcriptional profiling identifies Id2 function in dendritic cell development
Hacker, C., Kirsch, R. D., Ju, X.-S., Hieronymus, T., Gust, T. C., Kuhl, C., Jorgas, T., Kurz, S. M., Rose-John, S., Yokota, Y., et al. (2003) · Nature Immunology · doi:10.1038/ni903 · Cited by 544
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526
Hirota, H., Yoshida, K., Kishimoto, T., & Taga, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4862 · Cited by 505
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10915 · Cited by 429
Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., & Sasayama, S. (1998) · Circulation · doi:10.1161/01.cir.98.2.149 · Cited by 415
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406 · cited 1×
“It has long been known that IL6KO mice do not develop RA [103] but further studies have shown that targeting IL6”
BackgroundNakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390
Cytokine-Induced Modulation of Cardiac Function
Prabhu, S. D. (2004) · Circulation Research · doi:10.1161/01.res.0000150734.79804.92 · Cited by 375
Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy
Wollert, K. C., Taga, T., Saito, M., Narazaki, M., Kishimoto, T., Glembotski, C. C., Vernallis, A. B., Heath, J. K., Pennica, D., Wood, W. I., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9535 · Cited by 372
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
Mackiewicz, A., Schooltink, H., Heinrich, P. C., & Rose-John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 370
Yokota, S., Miyamae, T., Imagawa, T., Iwata, N., Katakura, S., Mori, M., Woo, P., Nishimoto, N., Yoshizaki, K., & Kishimoto, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20944 · Cited by 370
Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., & Entman, M. L. (1999) · Circulation · doi:10.1161/01.cir.99.4.546 · Cited by 342
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6
Yamauchi-Takihara, K., Ihara, Y., Ogata, A., Yoshizaki, K., Azuma, J., & Kishimoto, T. (1995) · Circulation · doi:10.1161/01.cir.91.5.1520 · Cited by 304
Kukielka, G. L., Smith, C. W., Manning, A. M., Youker, K. A., Michael, L. H., & Entman, M. L. (1995) · Circulation · doi:10.1161/01.cir.92.7.1866 · Cited by 295
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
Fischer, P., & Hilfiker-Kleiner, D. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0674-z · Cited by 272
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin, T., Taga, T., Tsang, M. L., Yasukawa, K., Kishimoto, T., & Yang, Y. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2555 · Cited by 262
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
Ulich, T. R., Yin, S., Guo, K., Yi, E. S., Remick, D. G., & del Castillo, J. M. G. (1991) · PubMed Central · Cited by 241
Interleukin 6 and liver regeneration
STREETZ, K. L., LUEDDE, T., MANNS, M. P., & TRAUTWEIN, C. (2000) · Gut · doi:10.1136/gut.47.2.309 · Cited by 238
Chapter 4 Pathogenesis of Myocarditis and Dilated Cardiomyopathy
Cihakova, D., & Rose, N. R. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00604-4 · Cited by 223
Self-citationDAWN, B. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.011 · Cited by 221
Woo, P., Wilkinson, N., Prieur, A.-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D., & Kishimoto, T. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1826 · Cited by 213
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Kallen, K.-J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00325-7 · Cited by 205
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
Targeting the Inflammatory Response in Healing Myocardial Infarcts
Frangogiannis, N. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585086 · Cited by 190
The Role of Interleukin-6 in the Failing Heart
Wollert, K. C., & Drexler, H. (2001) · Heart Failure Reviews · doi:10.1023/a:1011401825680 · Cited by 179
Interleukin-6 receptor pathways in abdominal aortic aneurysm
Harrison, S. C., Smith, A. J. P., Jones, G. T., Swerdlow, D. I., Rampuri, R., Bown, M. J., on behalf of the Aneurysm Consortium, Folkersen, L., Baas, A. F., de Borst, G. J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs354 · Cited by 177
Narimatsu, M., Maeda, H., Itoh, S., Atsumi, T., Ohtani, T., Nishida, K., Itoh, M., Kamimura, D., Park, S., Mizuno, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6615-6625.2001 · Cited by 173
Constitutive production of interleukin‐6 and immunologic features in cardiac myxomas
Jourdan, M., Bataille, R., Seguin, J., Zhang, X. G., Chaptal, P. A., & Klein, B. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330313 · Cited by 168
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor
Derouet, D., Rousseau, F., Alfonsi, F., Froger, J., Hermann, J., Barbier, F., Perret, D., Diveu, C., Guillet, C., Preisser, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306178101 · Cited by 168
Hilfiker-Kleiner, D., Shukla, P., Klein, G., Schaefer, A., Stapel, B., Hoch, M., Müller, W., Scherr, M., Theilmeier, G., Ernst, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933127 · Cited by 167
Yu, X., Kennedy, R. H., & Liu, S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212321200 · Cited by 166
Yoshizaki, K., Nishimoto, N., Mihara, M., & Kishimoto, T. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00832010 · Cited by 164
Hegde, S., Pahne, J., & Smola, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0969fje · Cited by 164
Yasukawa, H., Hoshijima, M., Gu, Y., Nakamura, T., Pradervand, S., Hanada, T., Hanakawa, Y., Yoshimura, A., Ross, J., & Chien, K. R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13939 · Cited by 164
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
Fischer, P., & Hilfiker-Kleiner, D. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0658-z · Cited by 162
Cash, H., Relle, M., Weinmann‐Menke, J., Brochhausen, C., Jones, S. A., Topley, N., Galle, P. R., & Schwarting, A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090194 · Cited by 161
Robak, T., Gladalska, A., Stepień, H., & Robak, E. (1998) · Mediators of Inflammation · doi:10.1080/09629359890875 · Cited by 161
IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice
Mihara, M., Takagi, N., Takeda, Y., & Ohsugi, Y. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00612.x · Cited by 159
Podewski, E. K., Hilfiker‐Kleiner, D., Hilfiker, A., Morawietz, H., Lichtenberg, A., Wollert, K. C., & Drexler, H. (2003) · Circulation · doi:10.1161/01.cir.0000057545.82749.ff · Cited by 155
Eriksson, U., Kurrer, M. O., Schmitz, N., Marsch, S. C., Fontana, A., Eugster, H.-P., & Kopf, M. (2003) · Circulation · doi:10.1161/01.cir.0000043802.38699.66 · Cited by 150
Interleukin-6 signal transducer gp130 mediates oncostatin M signaling.
Liu, J., Modrell, B., Aruffo, A. A., Marken, J. S., Taga, T., Yasukawa, K., Murakami, M., Kishimoto, T., & SHOYAB, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41845-5 · Cited by 147
INTERLEUKIN 6 KNOCK-OUT MICE ARE RESISTANT TO ANTIGEN-INDUCED EXPERIMENTAL ARTHRITIS
Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., & Serlupi‐Crescenzi, O. (1999) · Cytokine · doi:10.1006/cyto.1999.0502 · Cited by 142
Smart, N., Mojet, M. H., Latchman, D. S., Marber, M. S., Duchen, M. R., & Heads, R. J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.017 · Cited by 142
McLoughlin, R. M., Hurst, S. M., Nowell, M. A., Harris, D. A., Horiuchi, S., Morgan, L. W., Wilkinson, T. S., Yamamoto, N., Topley, N., & Jones, S. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5676 · Cited by 140
Audet, J., Miller, C., Rose‐John, S., Piret, J. M., & Eaves, C. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1757 · Cited by 138
Fischer, P., & Hilfiker‐Kleiner, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.1 · Cited by 136
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
Ogilvie, E. M., Fife, M. S., Thompson, S. D., Twine, N. A., Tsoras, M., Moroldo, M. B., Fisher, S. A., Lewis, C. M., Prieur, A., Glass, D. N., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11300 · Cited by 133
Quintana, A., Müller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J. C., Hidalgo, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900242 · Cited by 130
Kubota, T., Miyagishima, M., Alvarez, R., Kormos, R. L., Rosenblum, W. D., Demetris, A. J., Semigran, M. J., Dec, G. W., Holubkov, R., McTiernan, C. F., et al. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00173-x · Cited by 130
Gabriel, A. S., Martinsson, A., Wretlind, B., & Ahnve, S. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.07.013 · Cited by 124
Terrell, A. M., Crisostomo, P. R., Wairiuko, G. M., Wang, M., Morrell, E. D., & Meldrum, D. R. (2006) · Shock · doi:10.1097/01.shk.0000226341.32786.b9 · Cited by 123
Teague, T., Schaefer, B., Hildeman, D. A., Bender, J., Mitchell, T., Kappler, J., & Marrack, P. (2000) · Journal of Experimental Medicine · doi:10.1084/jem.191.6.915 · Cited by 115
Chandrasekar, B., Mitchell, D. H., Colston, J. T., & Freeman, G. L. (1999) · Circulation · doi:10.1161/01.cir.99.3.427 · Cited by 111
Chen, Q., Wang, W., Bruce, R., Li, H., Schleider, D. M., Mulbury, M. J., Bain, M. D., Wallace, P. K., Baumann, H., & Evans, S. S. (2004) · Immunity · doi:10.1016/s1074-7613(03)00358-3 · Cited by 110
Yang, S., Zheng, R., Hu, S., Ma, Y., Choudhry, M. A., Messina, J. L., Rue, L. W., Bland, K. I., & Chaudry, I. H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00624.2003 · Cited by 103
Curnow, J., Scheel‐Toellner, D., Jenkinson, W. E., Raza, K., Durrani, O. M., Faint, J., Rauz, S., Wloka, K., Pilling, D., Rose‐John, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5290 · Cited by 102
Association of Serum Interleukin-6 Concentration with a Functional IL6 −6331T>C Polymorphism
Smith, A. J. P., D’Aiuto, F., Palmen, J., Cooper, J. A., Samuel, J., Thompson, S. R., Sanders, J., Donos, N., Nibali, L., Brull, D. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.098608 · Cited by 101
Keul, R., Heinrich, P. C., Müller-Newen, G., Muller, K., & Woo, P. (1998) · Cytokine · doi:10.1006/cyto.1997.0343 · Cited by 98
Modification of Viral Myocarditis in Mice by Interleukin-6
Kanda, T., McManus, J. E. W., Nagai, R., Imai, S., Suzuki, T., Yang, D., McManus, B. M., & Kobayashi, I. (1996) · Circulation Research · doi:10.1161/01.res.78.5.848 · Cited by 89
Activation of the Cardiac Interleukin-6 System in Advanced Heart Failure
Plenz, G., Fang, S. Z., Tjan, T. D. T., Carsten, K., Baba Hideo, A., Erren, M., Flesch, M., Thomas, W., Scheld, H. H., & Deng Mario, C. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00137-4 · Cited by 89
Birks, E. J., Latif, N., Owen, V. J., Bowles, C. T., Felkin, L. E., Mullen, A. J., Khaghani, A., Barton, P. J. R., Polak, J. M., Pepper, J., et al. (2001) · Circulation · doi:10.1161/hc37t1.094872 · Cited by 87
Hirota, H., Izumi, M., 濱口, 智., et al. (2004) · Heart and Vessels · doi:10.1007/s00380-004-0770-z · Cited by 81
Yamauchi‐Takihara, & Kishimoto (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00139.x · Cited by 78
LeBlanc, R. A., Pesnicak, L., Cabral, E. S., Godleski, M., & Straus, S. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8145-8151.1999 · Cited by 65
Diao, H., & Kohanawa, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3745-3748.2005 · Cited by 63
The interleukin-6 pathway and atherosclerosis
Boekholdt, S. M., & Stroes, E. S. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60361-4 · Cited by 61
Interleukin‐6 Trans‐Signaling Exacerbates Inflammation and Renal Pathology in Lupus‐Prone Mice
Tsantikos, E., Maxwell, M. J., Putoczki, T. L., Ernst, M., Rose‐John, S., Tarlinton, D. M., & Hibbs, M. L. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38061 · Cited by 56
Coordination of interleukin-6 biology by membrane bound and soluble receptors
Rose‐John, S. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0685-0_19 · Cited by 55
Bleier, J. I. S., Pillarisetty, V. G., Shah, A. B., & DeMatteo, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7408 · Cited by 42
LOPEZ, N., Varo, N., Dı́ez, J., & Fortuño, M. A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.025 · Cited by 38
Identification of a novel regulatory region in the interleukin-6 gene promoter
Samuel, J., Kelberman, D., Smith, A. J. P., Humphries, S. E., & Woo, P. M. (2008) · Cytokine · doi:10.1016/j.cyto.2008.02.008 · Cited by 36
Florholmen, G., Thoresen, G. H., Rustan, A. C., Jensen, J., Christensen, G., & Aas, V. (2006) · Diabetologia · doi:10.1007/s00125-006-0150-6 · Cited by 26
Onogawa, T. (2005) · Immunobiology · doi:10.1016/j.imbio.2004.09.006 · Cited by 22
Smith, A. J. P., Zheng, D., Palmen, J., Pang, D., Woo, P. M., & Humphries, S. E. (2012) · Genes and Immunity · doi:10.1038/gene.2012.32 · Cited by 10
IL-6 KO MICE DEVELOP EXPERIMENTAL AMOEBIC LIVER INFECTION WITH EOSINOPHILIA
Estrada‐Villaseñor, E., Morales‐Montor, J., Rodríguez‐Dorantes, M., Ramos-Martínez, E., Néquiz, M., & Ostoa‐Saloma, P. (2007) · Journal of Parasitology · doi:10.1645/ge-1223.1 · Cited by 10
Cited by
Spatially resolved multiomics of human cardiac niches
Kanemaru, K., Cranley, J., Muraro, D., Miranda, A. M. A., Ho, S. Y., Wilbrey-Clark, A., Patrick Pett, J., Polanski, K., Richardson, L., Litvinukova, M., et al. (2023) · Nature · doi:10.1038/s41586-023-06311-1 · Cited by 425
The role of cytokines in the development of atherosclerosis
Fatkhullina, A. R., Peshkova, I. O., & Koltsova, E. K. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110134 · Cited by 323
The cellular composition of the human immune system is shaped by age and cohabitation
Carr, E. J., Dooley, J., Garcia-Perez, J. E., Lagou, V., Lee, J. C., Wouters, C., Meyts, I., Goris, A., Boeckxstaens, G., Linterman, M. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3371 · Cited by 316
Role of cytokines and inflammation in heart function during health and disease
Bartekova, M., Radosinska, J., Jelemensky, M., & Dhalla, N. S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9716-x · Cited by 293
Held, C., White, H. D., Stewart, R. A. H., Budaj, A., Cannon, C. P., Hochman, J. S., Koenig, W., Siegbahn, A., Steg, P. G., Soffer, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005077 · Cited by 291
Metadata
- Authors
- Fontes, J. A., Rose, N. R., & Čiháková, D.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 74
- Issue
- 1
- Pages
- 62-68
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W1984787542
- Cited by
- 337
- References
- 132
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.